Wyller, Vegard Bruun, Thaulow, Erik, Amlie, Jan P · The Journal of pediatrics · 2007 · DOI
This study looked at a teenager with ME/CFS who also experienced dizziness and fainting when standing up (orthostatic intolerance). The doctors treated this teen with propranolol, a blood pressure medication that slows the heart rate. The case suggests that an overactive stress-response system in the nervous system might contribute to ME/CFS symptoms, and that a simple tilt test could help identify patients who might benefit from this type of treatment.
For many ME/CFS patients, orthostatic symptoms are debilitating and poorly understood. This study offers a testable hypothesis linking these symptoms to abnormal nervous system regulation and suggests an existing medication class worth investigating further in controlled settings.
A single case report cannot prove that propranolol is effective for ME/CFS or that sympathetic overactivity causes the disease in most patients. The improvement observed could reflect placebo response, natural symptom fluctuation, or factors unrelated to the drug's mechanism. Larger, randomized controlled trials are essential before any treatment recommendation can be made.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Contribute
Private, reviewed by a human. Not a public comment thread.